Boehringer Ingelheim faces allegations that it failed to warn doctors about dangerous side effects of blood-thinning medication Pradaxa in two lawsuits in the Southern District of Florida. Courtesy photo.
Co-national leads for litigation against Boehringer Ingelheim Pharmaceuticals Inc., C. Andrew Childers of Childers, Schlueter & Smith in Atlanta and Neal Moskow of Ury & Moskow in Fairfield, Connecticut, have branched out with two Florida lawsuits in an attempt to avoid overcrowded Connecticut dockets.
August 26, 2019 at 02:24 PM
1 minute read
Two Florida plaintiffs have filed federal lawsuits against Connecticut-based drug giant Boehringer Ingelheim Pharmaceuticals Inc., accusing it of over-promoting and misrepresenting Pradaxa, a blood-thinning medication that alleges causes internal bleeding.
Pradaxa is used to prevent blood clots and lower the risk of stroke for patients with irregular heartbeats.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
